Leqvio Hair and Skin Changes: What the Evidence Can Show
Hair shedding after a Leqvio (inclisiran) injection deserves attention, even when the cause is uncertain. The available studies describe injection-site reactions more clearly than hair changes. They do not provide a dependable rate of hair loss caused by inclisiran or establish whether its risk matches the background rate.
What the studies establish
In the prescribing information’s pooled adult trials, injection-site reactions occurred in about 8% of inclisiran recipients and 2% of placebo recipients. This category includes pain, redness and rash where the injection was given. Those figures describe local reactions, not every possible skin problem.[1]
ORION-10 and ORION-11 followed 3,178 randomized participants for 540 days. Injection-site adverse events were generally mild, with none described as severe or persistent. These findings cannot promise a particular recovery time for every patient.[2]
Longer follow-up adds useful safety information. ORION-3 followed participants for four years, while ORION-8 reported a mean cumulative exposure of 3.7 years, including parent studies. Both were open-label extensions. They did not establish a quantified alopecia risk or exclude very rare reactions.[3][4]
Read the pattern before assigning a cause
Diffuse shedding, a discrete bald patch and redness at an injection site need different assessments. The table below connects an observable pattern with the limits of the evidence; it cannot identify the cause on its own.
| Symptom pattern | Useful next step | What the evidence cannot settle |
|---|---|---|
| Redness, soreness or swelling confined to the injection area | Photograph the area and note whether it is improving, spreading or becoming more painful; contact the treating team if worsening | Trial descriptions do not set a universal number of days for recovery |
| Increased shedding across the scalp | Record onset, recent illness and medication changes for a prescriber or dermatology review | Timing after an injection alone cannot establish a medication cause |
| A new smooth patch, broken hairs or inflamed scalp | Arrange an examination rather than assuming a specific type of alopecia | Inclisiran studies do not quantify alopecia areata risk |
| Hives away from the injection site, facial swelling or breathing difficulty | Seek immediate medical help; breathing or swallowing difficulty requires emergency care | A local injection-reaction percentage cannot estimate systemic allergy risk |
Serious hypersensitivity reactions have been reported after marketing. Voluntary reports cannot establish how often they occur.[1] MedlinePlus identifies rash, hives, swelling and breathing or swallowing difficulty as symptoms requiring immediate attention.[7]
Evaluating hair changes
Hair loss can have overlapping causes, including hereditary thinning, illness, major stress, thyroid disease, nutritional problems and medications.[6] A dermatologist may examine the scalp, nails and other body hair, and ask how quickly the change developed. Blood tests or a scalp biopsy may be appropriate when the history and examination suggest a particular condition; there is no automatic test panel for everyone.[5] Avoid assuming a deficiency and starting supplements without an assessment.
Keep a record that helps the appointment
Write down each injection date and the date you first noticed a change. Describe whether hair is shedding diffusely or disappearing in patches, and note scalp itching, scale, tenderness or redness. Include recent illnesses, significant stress and medication or supplement changes.
Keep injection-site photographs separate from scalp photographs. Label both with dates; repeat scalp pictures using similar lighting, hair parting and distance. This gives the clinician a clearer timeline without turning photographs into a diagnostic test.
Discuss the symptoms before deciding about another dose. The decision should account for their severity, the suspected cause and your individual cholesterol-lowering benefit. Suspected medication-related shedding is a reason to contact the prescriber, rather than stop treatment on your own.[6]
Frequently asked questions
Does Leqvio (inclisiran) cause hair loss?
The cited evidence does not quantify a causal hair-loss rate. Its absence from the common-reaction table cannot rule out an association.[1]
What skin reactions does inclisiran cause?
Local pain, redness or swelling can occur. Rash, itching, hives or swelling away from the site need immediate medical attention; breathing or swallowing difficulty requires emergency care.[7]
How long do Leqvio injection-site reactions last?
There is no reliable universal duration. ORION-10 and ORION-11 described these reactions as generally mild, with none severe or persistent, but did not establish a recovery deadline for everyone. Ask the treating team about a reaction that worsens or is not improving.[2]
Is inclisiran associated with alopecia areata?
The cited trial evidence does not quantify an alopecia areata association. A new bald patch needs examination because several conditions can cause patchy loss.[2][5]
Can I continue Leqvio if I am experiencing hair thinning?
Discuss this with your prescriber before the next dose rather than making an automatic decision to continue or stop. The assessment should consider the hair-loss pattern, other possible causes, symptom severity and your expected cholesterol-lowering benefit. Do not stop a suspected medication on your own.[6]
Does inclisiran affect skin differently in women versus men?
The cited trial report does not establish separate hair-loss or skin-reaction risks for women and men. An individual change needs its own evaluation.[2]
How does the injection-site reaction rate for Leqvio compare to evolocumab or alirocumab?
The cited inclisiran trials were placebo-controlled, not head-to-head comparisons with evolocumab or alirocumab. Percentages from separate trials may reflect different populations, follow-up and reporting methods, so they cannot reliably rank these medicines by injection-site risk.[2]
Does Leqvio cause photosensitivity?
Photosensitivity is not quantified in this label. Report a new sun-associated rash, its timing, and other medication exposures.[1]
Can patients with psoriasis or eczema take inclisiran?
Ask your clinician about the affected skin and allergy history. The injection should avoid active rash, inflamed or infected skin.[1]
What should I tell my doctor if I notice hair changes on Leqvio?
Bring injection and symptom dates, dated photographs, and a description of diffuse shedding versus patches. Mention scalp symptoms, recent illness, stress and medication changes. The examination determines whether targeted blood tests or a biopsy would help; everyone does not need the same tests.[5][6]
Is Leqvio self-injected like other PCSK9 inhibitors?
Leqvio is given by a healthcare professional.[1]
References
Sources checked October 14, 2026.
- LEQVIO (inclisiran) prescribing information — adverse reactions, hypersensitivity and administration. DailyMed.
- Ray et al. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol — ORION-10 and ORION-11. 2020.
- Ray et al. Long-term efficacy and safety of inclisiran — the four-year ORION-3 extension. 2023.
- Wright et al. Long-term inclisiran treatment — results from ORION-8. 2024.
- Hair loss: Diagnosis and treatment. American Academy of Dermatology.
- Hair loss: Who gets and causes. American Academy of Dermatology.
- Inclisiran injection — patient drug information and urgent symptoms. MedlinePlus.
